These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 31477078)

  • 21. Association of Blood Fatty Acid Composition and Dietary Pattern with the Risk of Non-Alcoholic Fatty Liver Disease in Patients Who Underwent Cholecystectomy.
    Shim P; Choi D; Park Y
    Ann Nutr Metab; 2017; 70(4):303-311. PubMed ID: 28595185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lifestyle predictors of obese and non-obese patients with nonalcoholic fatty liver disease: A cross-sectional study.
    Kwak JH; Jun DW; Lee SM; Cho YK; Lee KN; Lee HL; Lee OY; Choi HS; Yoon BC
    Clin Nutr; 2018 Oct; 37(5):1550-1557. PubMed ID: 28918170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nonalcoholic Fatty Liver Disease and Estimated Insulin Resistance in Obese Youth: A Mendelian Randomization Analysis.
    Morandi A; Di Sessa A; Zusi C; Umano GR; El Mazloum D; Fornari E; Miraglia Del Giudice E; Targher G; Maffeis C
    J Clin Endocrinol Metab; 2020 Nov; 105(11):. PubMed ID: 32841326
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abdominal Obesity as a Predictive Factor of Nonalcoholic Fatty Liver Disease Assessed by Ultrasonography and Transient Elastography in Polycystic Ovary Syndrome and Healthy Women.
    Tantanavipas S; Vallibhakara O; Sobhonslidsuk A; Phongkitkarun S; Vallibhakara SA; Promson K; Sophonsritsuk A
    Biomed Res Int; 2019; 2019():9047324. PubMed ID: 31467918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonalcoholic Fatty Liver Disease Is an Independent Risk Factor for Nephrolithiasis in Women: Findings from NHANES III.
    Decker RD; Ghiraldi EM; Weiss AH; Gaughan JP; Friedlander JI
    J Endourol; 2020 Dec; 34(12):1258-1262. PubMed ID: 32571100
    [No Abstract]   [Full Text] [Related]  

  • 26. Prevalence, risk factors, and predictors of nonalcoholic fatty liver disease among schoolchildren: a hospital-based study in Alexandria, Egypt.
    Alkassabany YM; Farghaly AG; El-Ghitany EM
    Arab J Gastroenterol; 2014 Jun; 15(2):76-81. PubMed ID: 25097051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nonalcoholic fatty liver disease in lean individuals in the United States.
    Younossi ZM; Stepanova M; Negro F; Hallaji S; Younossi Y; Lam B; Srishord M
    Medicine (Baltimore); 2012 Nov; 91(6):319-327. PubMed ID: 23117851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of insulin resistance in the occurence of non-alcoholic fatty liver disease among first degree relatives of type 2 diabetes.
    Hazim A; Purnamasari D; Kalista KF; Lesmana CRA; Nugroho P
    Diabetes Metab Syndr; 2019; 13(2):1431-1435. PubMed ID: 31336502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonalcoholic fatty liver disease prevalence in urban school-aged children and adolescents from the Yangtze River delta region: a cross-sectional study.
    Zhang X; Wan Y; Zhang S; Lu L; Chen Z; Liu H; Jiang X; Luo K; Cai W
    Asia Pac J Clin Nutr; 2015; 24(2):281-8. PubMed ID: 26078245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nonalcoholic fatty liver disease, cholesterol gallstones, and cholecystectomy: new insights on a complex relationship.
    Arrese M; Cortés V; Barrera F; Nervi F
    Curr Opin Gastroenterol; 2018 Mar; 34(2):90-96. PubMed ID: 29266009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive Value of Adiposity Level, Metabolic Syndrome, and Insulin Resistance for the Risk of Nonalcoholic Fatty Liver Disease Diagnosis in Obese Children.
    Prokopowicz Z; Malecka-Tendera E; Matusik P
    Can J Gastroenterol Hepatol; 2018; 2018():9465784. PubMed ID: 29854716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between aspirin use and the prevalence of nonalcoholic fatty liver disease: a cross-sectional study from the Third National Health and Nutrition Examination Survey.
    Shen H; Shahzad G; Jawairia M; Bostick RM; Mustacchia P
    Aliment Pharmacol Ther; 2014 Nov; 40(9):1066-73. PubMed ID: 25176122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histamine H2-Receptor Antagonist Use Is Associated With Lower Prevalence of Nonalcoholic Fatty Liver Disease: A Population-based Study From the National Health and Nutrition Examination Survey, 2001-2006.
    Shen H; Liangpunsakul S
    J Clin Gastroenterol; 2016 Aug; 50(7):596-601. PubMed ID: 26905606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin-like growth factor 1 and metabolic parameters are associated with nonalcoholic fatty liver disease in obese children and adolescents.
    Liang S; Cheng X; Hu Y; Song R; Li G
    Acta Paediatr; 2017 Feb; 106(2):298-303. PubMed ID: 27889912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonalcoholic Fatty Liver Disease Relationship with Metabolic Syndrome in Class III Obesity Individuals.
    Cordeiro A; Pereira SE; Saboya CJ; Ramalho A
    Biomed Res Int; 2015; 2015():839253. PubMed ID: 26120587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. C-peptide as a key risk factor for non-alcoholic fatty liver disease in the United States population.
    Atsawarungruangkit A; Chenbhanich J; Dickstein G
    World J Gastroenterol; 2018 Aug; 24(32):3663-3670. PubMed ID: 30166861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-alcoholic fatty liver disease and its associated risk factors in Brazilian postmenopausal women.
    Bruno Ade S; Rodrigues MH; Alvares MC; Nahas-Neto J; Nahas EA
    Climacteric; 2014 Aug; 17(4):465-71. PubMed ID: 24517420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ultrasonographically detected non-alcoholic fatty liver disease is an independent predictor for identifying patients with insulin resistance in non-obese, non-diabetic middle-aged Asian adults.
    Sinn DH; Gwak GY; Park HN; Kim JE; Min YW; Kim KM; Kim YJ; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
    Am J Gastroenterol; 2012 Apr; 107(4):561-7. PubMed ID: 22108448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between Dietary Niacin Intake and Nonalcoholic Fatty Liver Disease: NHANES 2003-2018.
    Pan J; Hu Y; Pang N; Yang L
    Nutrients; 2023 Sep; 15(19):. PubMed ID: 37836412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low serum potassium level is associated with nonalcoholic fatty liver disease and its related metabolic disorders.
    Sun K; Lu J; Jiang Y; Xu M; Xu Y; Zhang J; Xu B; Sun J; Sun W; Ren C; Liu J; Wang W; Bi Y; Ning G
    Clin Endocrinol (Oxf); 2014 Mar; 80(3):348-55. PubMed ID: 23405890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.